Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the "Ph1-negative Myeloproliferative Neoplasms Latium Group".
Mazzucconi MG, Baldacci E, Latagliata R, Breccia M, Paoloni F, Di Veroli A, Cedrone M, Anaclerico B, Villivà N, Porrini R, Montefusco E, Andriani A, Montanaro M, Scaramucci L, Spadea A, Rago A, Cimino G, Spirito F, Santoro C.
Mazzucconi MG, et al. Among authors: baldacci e.
Eur J Haematol. 2020 Sep;105(3):335-343. doi: 10.1111/ejh.13454. Epub 2020 Jun 16.
Eur J Haematol. 2020.
PMID: 32441419